Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Evaluación clínica de Una tecnología Ambulatoria Para diagnóstico Del sueño
This trial will aim to test a new wearable device for the diagnosis of Sleep Apnoea.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
This clinical trial will test a new wearable device for the diagnosis of Sleep Apnoea against Multi-channel polygraphy and Polysomnography.
For Group 1 and Group 2, the patients who have been referred for a sleep apnoea diagnosis will undergo in-hospital overnight polysomnography while wearing the new wearable device. Performance (i.e. sensitivity and specificity) of the new device will be assessed against the gold standard system.
For Group 3 and 4, the patients who have been referred for a sleep apnoea diagnosis will undergo in-hospital overnight polysomnography while wearing the new wearable device and a CE-marked oximeter.
For Group 5, patients presenting clinical criteria of Restless Legs Syndrome who are being evaluated via sleep studies as part of a routine clinical care will undergo an overnight polysomnography while wearing the new wearable device system.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Renard Pramono, PhD
- Phone Number: +447721 877020
- Email: renard@acurable.com
Study Locations
-
-
-
Seville, Spain
- Recruiting
- Hospital Virgen Macarena Sevilla
-
Contact:
- Jesus Gomez Sanchez, Dr
- Email: orsina@acurable.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients who have been referred for suspicion of sleep apnoea
Description
Inclusion Criteria:
- Patients who have been referred to a sleep clinic due to suspicion of sleep apnoea.
- patients between the age of 18 yo and 80 yo
Exclusion Criteria:
- who are not fluent in Spanish, or who have special communication needs.
- Known allergy to the adhesive dressing.
- patients with physical or mental impairments who would not be able to use the new technology on their own.
- patients with very loose/saggy skin in the neck area which would unavoidably result on AcuPebble swinging if moving the neck.
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: PROSPECTIVE
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Group 2: PSG and novel wearable device
75 patients will wear polysomnography at the same time as the Novel wearable device |
patient will wear novel wearable device overnight along with normal standard of care |
|
Group 3: PSG and novel wearable device (+ CE-marked pulse oximeter)
51 patients (plus up to 20% to account for possible dropouts) will wear polysomnography at the same time as the novel wearable device and a CE-marked pulse-oximeter. |
patient will wear novel wearable device overnight along with normal standard of care |
|
Group 4: Additional PSG and novel wearable device (+ CE-marked pulse oximeter)
Additional 75 consecutive patients will wear polysomnography at the same time as the novel wearable device and a CE-marked pulse-oximeter. |
|
|
Group 1: Test Group
A first group of ~10-15 patients will be recruited, chosen from those who have been referred for a sleep apnea diagnosis. This group will not be used for performance validation, but rather to train all relevant staff on the different steps of the protocol and for the initial investigation of some of the secondary objectives related to usability. |
|
|
Group 5: RLS
70 patients presenting clinical criteria compatible with Restless legs Syndrome and who are being evaluated for a sleep study as part of their routine clinical care will be included. The patients will wear standard polysomnography while simultaneously wearing the new wearable system (a total of 4 sensors: 1 sensor on the neck, 1 pulse oximeter on finger, and 1-2 sensors on the legs). |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivities and Specificity for diagnosis of sleep apnoea studies with novel wearable device
Time Frame: 6 months
|
The study aims to compare the diagnosis result of the novel wearable device against standard of care |
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jesus Fernando Sanchez Gomez, MD, Hospital Universitario Virgen Macarena
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 720/19/EC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.